Menu
Annual · values202520242023202220212020
Operating Cash Flow-11.99 M USD-17.14 M USD-22.33 M USD-23.03 M USD-25.22 M USD-20.14 M USD
Depreciation & Amortization
Stock-Based Compensation
Capital Expenditures
Cash Flow from Investing
Cash Flow from Financing
Dividends Paid
Stock Buybacks
Free Cash Flow-13.64 M USD-20.33 M USD-22.36 M USD-24.85 M USD-25.56 M USD-20.20 M USD

Evogene Ltd. is a biotechnology company that focuses on developing innovative solutions across various life science-based industries, including agriculture, pharmaceuticals, and industrial applications. By leveraging its unique computational predictive biology platform, Evogene aims to evolve new products through enhanced efficiency and precision. The platform integrates extensive databases, advanced algorithms, and big data analytics to identify and optimize traits that increase yield, resistance, and sustainability in crops or address critical health and industrial challenges. As a key player in sectors such as agrochemicals, seed development, and biotechnology, Evogene has established collaborations with leading companies to commercially scale its proprietary discoveries. The company is headquartered in Rehovot, Israel, contributing significantly to advancements in biotechnology that enhance productivity and sustainability, reflecting its growing importance in the global market for biologically driven solutions.